EXABLATE 4000
Report
- Report Number
- 9615085-2022-00025
- Event Type
- Death
- Date Received
- September 22, 2022
- Date of Event
- August 5, 2022
- Report Date
- September 22, 2022
- Manufacturer
- INSIGHTEC LTD.
- Product Code
- POH
- UDI-DI
- 07290015461091
- PMA / PMN Number
- P150038
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NC, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
NO DEVICE MALFUNCTION WAS DETECTED. TREATMENT PARAMETERS WERE IN LINE WITH THE TYPICAL RANGE. THE SYSTEM PERFORMANCE WAS FOUND TO BE AS EXPECTED. NO NEW RISKS WERE IDENTIFIED. THE INTERNAL INVESTIGATION ANALYSIS COULD NOT FIND ANY RELATION BETWEEN THE TREATMENT AND PATIENT'S HEART ATTACK. THIS IS IN LINE WITH THE NEUROSURGEON'S VIEW WHO ADVISED IT SEEMS UNLIKELY THAT HIS HEART ATTACK WAS DIRECTLY RELATED TO TREATMENT.
PATIENT WAS TREATED ON (B)(6) 2022, FOR ESSENTIAL TREMOR (ET). THE PATIENT LEFT WITH TREMOR RELIEF AND PARESTHESIA IN HIS RIGHT LEG THAT HE MENTIONED WAS STARTING TO RESOLVE. POST OP MR IMAGES THAT WERE TAKEN IMMEDIATELY AFTER THE TREATMENT SHOWED A SMALL, FOCAL LESION WITH NO VISIBLE NECROTIC CORE AND LITTLE EDEMA. ON (B)(6), PATIENT COMPLAINED OF CHEST PAIN WHICH RESOLVED WITH ANTACIDS. THIS WAS SUSPECTED AS HEARTBURN. ON (B)(6) (11 DAYS AFTER TREATMENT), PATIENT DEVELOPED CHEST PAIN AGAIN, AND WAS ADMITTED TO THE HOSPITAL WHERE HE WAS DIAGNOSED WITH A MYOCARDIAL INFARCTION AND TREATMENT WAS ATTEMPTED IN THE CATHLAB. HE DIED SHORTLY THEREAFTER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2751803 | EXABLATE 4000 | MR GUIDED FOCUSED ULTRASOUND SYSTEM | POH | INSIGHTEC LTD. | 4000 | 07290015461091 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown | Disability| D |